NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
40 hedge funds and large institutions have $3.85M invested in NeuBase Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
-9
Holders Change %
-18.37%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
7
Closed
8
Calls
$6K
Puts
$60K
Net Calls
-$54K
Net Calls Change
+$135K
Top Buyers
1 |
BlackRock
New York
|
+$435K |
2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$293K |
3 |
Renaissance Technologies
New York
|
+$135K |
4 |
VKH
Virtu KCG Holdings
New York
|
+$50.6K |
5 |
ARTA
A.R.T. Advisors
New York
|
+$34K |